Gsk (GSK) Change in Intangibles (2009 - 2026)

Gsk (GSK) has 18 years of Change in Intangibles data on file, last reported at $476.6 million in Q3 2026.

• For the quarter ending Q3 2026, Change in Intangibles changed N/A year-over-year to $476.6 million; the trailing twelve-month figure through Sep 2026 stood at $1.1 billion (changed N/A YoY), and the FY2025 full-year result was $153.0 million, down 8.65% from the prior year.
• Change in Intangibles was $476.6 million for Q3 2026 at Gsk, up from $393.1 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $476.6 million in Q3 2026 to a low of $1.3 million in Q2 2024.
• A 5-year average of $112.0 million and a median of $76.2 million in 2022 frame the typical range for Change in Intangibles.
• Across the five-year window, Change in Intangibles slumped 98.52% in 2022 and surged 604.44% in 2024, its largest moves.
• Gsk's Change in Intangibles stood at $76.2 million in 2022, then slumped by 86.87% to $10.0 million in 2023, then jumped by 258.99% to $35.9 million in 2024, then jumped by 325.65% to $153.0 million in 2025, then soared by 211.59% to $476.6 million in 2026.
• Per Business Quant data, the three most recent Change in Intangibles figures were $476.6 million in Q3 2026, $393.1 million in Q2 2026, and $83.6 million in Q1 2026.